Bharat Parenterals Key Ratios
BSE: 541096
₹1,540.20
As on 24-Sep-2026 10:58IST
Market cap
₹1,059 Cr
Revenue (TTM)
₹323 Cr
P/E Ratio
--
P/B Ratio
3.3
Div. Yield
0.1 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -5.91 | -19.19 | -11.19 | 7.27 | 8.94 |
| EBIT | 98.34 | -102.94 | -3.75 | -201.68 | -202.19 |
| Net Profit | 121.02 | -87.75 | -171.45 | -187.85 | -193.56 |
| EPS | 121.02 | -87.75 | -152.69 | -182.81 | -190.17 |
| Book Value | -- | -- | -2.55 | 13.99 | 13.31 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 8.15 | 1.69 | -7.35 | -5.34 | -9.58 |
| Net Margin
| 7.76 | 0.03 | -9.01 | -7.69 | -12.41 |
| Return on equity
| 8.02 | 0.62 | -4.72 | -8.36 | -16.55 |
| Return on Capital
| 9.91 | 6.16 | -- | -1.82 | -4.85 |
| Return on Assets
| 5.02 | 1.18 | -4.75 | -4.28 | -7.52 |
| Debt to Equity (x)
| -- | -- | 0.38 | 0.45 | 0.54 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
--
|
-1.82
|
-4.85
|
7.74
|
12.57
|
|
Peer Median
|
--
|
19.34
|
21.76
|
21.89
|
--
|
ROE
-4.72
Lower than Peers by 20.06
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-4.72
|
-8.36
|
-16.55
|
5.54
|
9.03
|
|
Peer Median
|
15.35
|
17.67
|
17.93
|
16.42
|
--
|
ROA
-4.75
Lower than Peers by 15.10
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-4.75
|
-4.28
|
-7.52
|
2.46
|
5.45
|
|
Peer Median
|
10.35
|
9.88
|
12.81
|
12.32
|
--
|
EBIT Margin
-7.35
Lower than Peers by 25.35
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-7.35
|
-5.34
|
-9.58
|
6.90
|
6.47
|
|
Peer Median
|
18.01
|
18.96
|
18.93
|
21.05
|
--
|
Net Margin
-9.01
Lower than Peers by 23.47
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-9.01
|
-7.69
|
-12.41
|
3.95
|
6.83
|
|
Peer Median
|
14.45
|
13.32
|
14.94
|
15.51
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
--
|
2.01
|
-2.45
|
7.45
|
9.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-11.19
Lower than Peers by 23.14
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-11.19
|
1.48
|
30.31
|
19.83
|
2.81
|
|
Peer Median
|
11.95
|
12.97
|
10.90
|
13.44
|
--
|
EBIT Growth
-3.75
Lower than Peers by 25.34
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-3.75
|
43.49
|
-281.06
|
27.70
|
-33.61
|
|
Peer Median
|
21.60
|
15.05
|
15.01
|
23.50
|
--
|
Net Profit Growth
-171.45
Lower than Peers by 194.19
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-171.45
|
37.48
|
-515.39
|
-33.09
|
-24.49
|
|
Peer Median
|
22.73
|
11.89
|
14.80
|
30.12
|
--
|
EPS Growth
-152.69
Lower than Peers by 172.72
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-152.69
|
35.15
|
-173.44
|
-12.16
|
-22.11
|
|
Peer Median
|
20.03
|
12.16
|
14.27
|
29.02
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
--
|
-2.55
|
67.63
|
8.23
|
9.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.38
Higher than Peers by 0.37
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
0.38
|
0.45
|
0.54
|
0.80
|
0.27
|
|
Peer Median
|
0.00
|
0.05
|
0.06
|
0.03
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
--
|
0.05
|
0.30
|
0.41
|
0.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.97
Lower than Peers by 0.11
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
1.97
|
1.97
|
1.58
|
1.38
|
1.54
|
|
Peer Median
|
2.08
|
1.93
|
1.90
|
2.23
|
--
|
Quick Ratio
1.43
Lower than Peers by 0.10
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
1.43
|
1.43
|
1.27
|
1.06
|
1.22
|
|
Peer Median
|
1.54
|
1.52
|
1.46
|
1.59
|
--
|
Interest Coverage
-1.25
Lower than Peers by 20.63
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-1.25
|
-0.71
|
-1.62
|
5.66
|
10.07
|
|
Peer Median
|
19.38
|
19.95
|
24.96
|
45.29
|
--
|
Operating Efficiency
Debtors to sales
46.62
Higher than Peers by 25.24
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
46.62
|
43.61
|
50.46
|
54.14
|
51.57
|
|
Peer Median
|
21.38
|
19.87
|
21.77
|
20.10
|
--
|
Asset Turnover
0.51
Lower than Peers by 0.21
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
0.51
|
0.54
|
0.59
|
0.61
|
0.76
|
|
Peer Median
|
0.72
|
0.77
|
0.76
|
0.81
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
--
|
170.08
|
167.50
|
176.78
|
155.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
--
|
82.65
|
71.36
|
69.16
|
49.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
--
|
131.69
|
122.16
|
127.69
|
99.70
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
--
|
121.04
|
116.70
|
118.25
|
104.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-68.76
Lower than Peers by 102.23
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
-68.76
|
--
|
--
|
44.99
|
11.83
|
|
Peer Median
|
33.47
|
34.47
|
26.81
|
39.85
|
--
|
Price / Book Value
3.32
Lower than Peers by 1.85
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
3.32
|
1.93
|
2.06
|
3.31
|
1.06
|
|
Peer Median
|
5.17
|
5.82
|
4.65
|
6.11
|
--
|
Dividend Yield
0.07
Lower than Peers by 0.34
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
0.07
|
0.11
|
0.10
|
0.09
|
0.22
|
|
Peer Median
|
0.41
|
0.50
|
0.61
|
0.37
|
--
|
EV/EBITDA
59.14
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
59.14
|
29.75
|
56.08
|
25.07
|
7.30
|
|
Peer Median
|
--
|
29.65
|
27.02
|
34.57
|
--
|
Market Cap
1,059
Lower than Peers by 19,225
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Bharat Parenterals
|
1,059
|
620
|
681
|
653
|
194
|
|
Peer Median
|
20,284
|
17,998
|
20,914
|
25,297
|
--
|